- AI predicted to add US$182 billion to UAE's economy by 2035 with the healthcare industry taking a US$22 billion slice of the gains in its GVA
- Artificial Intelligence conference takes place from 4-7 February 2019 at MEDLAB Exhibition & Congress in Dubai, UAE
Dubai, United Arab Emirates: MEDLAB, the MENA region’s largest medical laboratory exhibition and congress, has announced the launch of its inaugural Artificial Intelligence (AI) conference taking place during the 18th edition of the show, which will run from 4–7 February 2019 at the Dubai World Trade Centre, Dubai, United Arab Emirates.
The conference will explore the potential for AI to transform the medical laboratory industry in the UAE through improved efficiencies and how diagnosis can be revolutionised through futuristic technologies such as data robots and “bloodless blood tests”.
With AI predicted to add US$182 billion to UAE's economy by 2035 and the healthcare industry taking a US$22 billion slice of the gains in its gross value added (GVA), medical laboratories across the country are preparing for the “AI lab of the future”.
Adding to this, the UAE Strategy for Artificial Intelligence - launched in 2017 – and the appointment of the country’s first UAE Minister of State for Artificial Intelligence, aims to make the country a world leader in the field of AI investments in healthcare in order to minimise chronic and dangerous diseases.
Commenting as Chair of the Artificial Intelligence conference at MEDLAB, Dr P. K. Menon, Director and COO of UAE-based Thumbay Labs, said: “The medical laboratory has been one of the earliest to adapt robotics and AI into its workflow. As early as 1984, the EXPERT consultation system-building tool, a knowledge-based AI programme, was developed at Rutgers University for enabling sequential laboratory testing and interpretation. Now, with the staggering increase in the volume of patient healthcare data, a constant increase in patient expectations and scarcity of resources, AI will be the engine driving improvements across the care continuum.”
“Today’s clinical labs are already using advanced robotics to test minute volumes of blood, serum and other bodily fluids from thousands of samples in a day to give highly accurate and reproducible answers to clinical questions, in scales almost difficult to emulate humanly. In the future, robots used in the clinical laboratory will be heuristic (self-learning), using inferential processes, with numerous ways to derive the best decision possible - even allowing for missing information. AI programmes will change the way our laboratories generate and display clinical information in the future,” he added.
Globally, a number of transformative advancements are being made by the adoption of revolutionary AI technologies in the medical laboratory. Earlier this year, scientists at the Mayo Clinic submitted a bloodless blood test for approval to the U.S. Food and Drug Administration (FDA) in order to create a test that people could do at home, without drawing blood. The algorithm can determine serum potassium levels in the blood by monitoring small changes in electrocardiogram (ECG) waves.
In the UAE, Abu Dhabi-headquartered National Reference Laboratory (NRL) is planning to adopt AI methodologies in the near future as an essential component of NRL’s molecular diagnostic laboratory services, and, with that, be at the forefront of using advanced technology to improve patient outcomes in the UAE and the region.
“It is anticipated that with the aid of AI, there will be an acceleration in novel gene discovery, therefore ending the diagnostic odyssey for many undiagnosed genetic diseases. AI will have a pivotal role in translating genomic research into actionable bedside applications that will benefit both providers and patients, and help in the fulfillment of the promise of precision medicine in the region,” said Dr Val Zvereff, Technical Director of Molecular Genetics at NRL.
Along with the Artificial Intelligence conference, the 2019 edition of MEDLAB will see the introduction of two more new tracks - Immunology and Cytogenetics & IVF - bringing the total number of CME-accredited conferences to 11. As the region’s only CME-accredited multi-disciplinary medical laboratory congress, MEDLAB is supporting the healthcare advancements in the region by providing exceptional education as well as management solutions to help advance laboratory skills and improve laboratory functions. Alongside the Congress, MEDLAB will also host an exhibition with 678+ exhibiting companies from 46 countries, facilitating the exploration of new business opportunities in the global medical laboratory field.
For a closer look at MEDLAB 2019, please visit www.medlabme.com
-Ends-
About MEDLAB
As the MENA region’s largest medical laboratory exhibition and congress, MEDLAB plays a crucial role in developing the value of laboratory medicine in shaping the future of healthcare by providing a platform for laboratory industry leaders, including manufacturers, dealers and distributors, to share best practice, showcase new innovations, collaborate and network.
MEDLAB stems from 15 years of growth alongside the MENA region's largest healthcare event, Arab Health. Moving into its 3rd year as a stand-alone show, this annual medical laboratory meeting brings together exhibitors and attendees from 160 countries, giving them the opportunity to present the latest innovations, as well as access cutting-edge laboratory products and services.
A focus point of MEDLAB is its 11 CME-accredited multi-disciplinary conference tracks covering topics such as laboratory management, molecular diagnostics and genetics, and clinical chemistry. This year's congress will introduce three new tracks, covering immunology, Artificial Intelligence (AI) and Cytogenetics and IVF in an effort to provide advanced medical laboratory techniques for better health.
MEDLAB will take place from 4 - 7 February 2019 at the Dubai World Trade Centre, Dubai, UAE.
Website: www.medlabme.com
Facebook: www.facebook.com/medlabseries
Twitter: @MedlabSeries #MEDLABme
For more information, please contact Shamal Communications:
Media Contact
JAMES LAKIE
General Manager
Tel: +971 4 365 2709
E-mail: james.lakie@shamalcomms.com
Office 106, Arjaan Office Tower, Dubai Media City
PO Box 502701 | Dubai, United Arab Emirates
Website: www.shamalcomms.com
A member of the WorldWisePR Affiliates
© Press Release 2018Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
